Timothy P. Noyes

Insider Reports History

Location
Waltham, MA
Signature
/s/ George A. Eldridge, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy P. Noyes:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (Right to Buy) 343,381 $5,621,147 $16.37 16 May 2024 Direct
Aerovate Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 0 $0 $21.92 16 May 2024 Direct

Insider Reports Filed by Timothy P. Noyes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JBIO Aerovate Therapeutics, Inc. 16 May 2024 4 -$194,355 4 CHIEF EXECUTIVE OFFICER, Director 17 May 2024, 19:10
JBIO Aerovate Therapeutics, Inc. 01 May 2024 5 -$209,546 4 CHIEF EXECUTIVE OFFICER, Director 03 May 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 16 Apr 2024 4 -$225,571 4 CHIEF EXECUTIVE OFFICER, Director 18 Apr 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 01 Apr 2024 6 -$278,633 4 CHIEF EXECUTIVE OFFICER, Director 03 Apr 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 29 Jan 2024 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 31 Jan 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 01 Nov 2023 1 -$11,379 4 CHIEF EXECUTIVE OFFICER, Director 03 Nov 2023, 17:00
JBIO Aerovate Therapeutics, Inc. 28 Jul 2023 3 -$86,881 4 CHIEF EXECUTIVE OFFICER, Director 01 Aug 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 17 Jul 2023 3 -$72,219 4 CHIEF EXECUTIVE OFFICER, Director 19 Jul 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 03 Jul 2023 3 -$158,600 4 CHIEF EXECUTIVE OFFICER, Director 05 Jul 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 01 May 2023 4 -$291,645 4 CHIEF EXECUTIVE OFFICER, Director 03 May 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 03 Apr 2023 4 -$258,816 4 CHIEF EXECUTIVE OFFICER, Director 05 Apr 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 07 Mar 2023 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 08 Mar 2023, 17:00
JBIO Aerovate Therapeutics, Inc. 01 Mar 2023 6 -$325,096 4 CHIEF EXECUTIVE OFFICER, Director 03 Mar 2023, 17:00
JBIO Aerovate Therapeutics, Inc. 01 Feb 2023 4 -$308,097 4 CHIEF EXECUTIVE OFFICER, Director 03 Feb 2023, 17:00
JBIO Aerovate Therapeutics, Inc. 03 Jan 2023 6 -$373,976 4 CHIEF EXECUTIVE OFFICER, Director 05 Jan 2023, 16:00
JBIO Aerovate Therapeutics, Inc. 01 Dec 2022 3 -$237,900 4 CHIEF EXECUTIVE OFFICER, Director 02 Dec 2022, 18:00
JBIO Aerovate Therapeutics, Inc. 01 Nov 2022 1 -$20,241 4 CHIEF EXECUTIVE OFFICER, Director 03 Nov 2022, 17:00
JBIO Aerovate Therapeutics, Inc. 14 Dec 2021 1 $0 4 Chief Executive Officer, Director 16 Dec 2021, 17:00
JBIO Aerovate Therapeutics, Inc. 29 Jun 2021 0 $0 3 Chief Executive Officer, Director 29 Jun 2021, 19:42
JBIO Aerovate Therapeutics, Inc. 02 Apr 2021 3 $0 4 Chief Executive Officer, Director 01 Jul 2021, 18:32
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .